Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE: 300702)
China
· Delayed Price · Currency is CNY
16.36
-0.04 (-0.24%)
Jan 3, 2025, 1:19 PM CST
Zhejiang Tianyu Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 495.2 | 426.15 | 476.98 | 476.75 | 1,296 | 142.1 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 6.98 | Upgrade
|
Trading Asset Securities | - | - | - | 72.94 | 37.91 | - | Upgrade
|
Cash & Short-Term Investments | 495.2 | 426.15 | 476.98 | 549.7 | 1,334 | 149.07 | Upgrade
|
Cash Growth | 14.09% | -10.66% | -13.23% | -58.80% | 794.97% | -73.44% | Upgrade
|
Accounts Receivable | 552.59 | 583.07 | 455.15 | 489.08 | 443.07 | 345.78 | Upgrade
|
Other Receivables | 5.05 | 5.01 | 6.4 | 6.22 | 9.3 | 1.7 | Upgrade
|
Receivables | 557.64 | 588.09 | 461.56 | 495.3 | 452.36 | 347.48 | Upgrade
|
Inventory | 1,884 | 1,890 | 2,017 | 1,599 | 994.84 | 871.97 | Upgrade
|
Other Current Assets | 61.5 | 47.38 | 61.95 | 188.71 | 129.56 | 112.43 | Upgrade
|
Total Current Assets | 2,999 | 2,951 | 3,018 | 2,832 | 2,911 | 1,481 | Upgrade
|
Property, Plant & Equipment | 2,817 | 2,793 | 2,810 | 2,465 | 1,663 | 1,177 | Upgrade
|
Long-Term Investments | 113.81 | 89.85 | 87.57 | 78.61 | 10.06 | 10.5 | Upgrade
|
Other Intangible Assets | 395.79 | 374.8 | 366.82 | 374.75 | 241.34 | 165.71 | Upgrade
|
Long-Term Deferred Tax Assets | 12.2 | 8.25 | 15.86 | 15 | 9.05 | 3.17 | Upgrade
|
Long-Term Deferred Charges | 57.52 | 77.57 | 60.54 | 3.55 | 1.17 | 1.38 | Upgrade
|
Other Long-Term Assets | 34.43 | 43.38 | 57.27 | 31.49 | 53.55 | 1.26 | Upgrade
|
Total Assets | 6,430 | 6,338 | 6,416 | 5,801 | 4,890 | 2,840 | Upgrade
|
Accounts Payable | 963.94 | 803.06 | 1,358 | 1,173 | 803.6 | 562.27 | Upgrade
|
Accrued Expenses | 70.83 | 118.32 | 140.45 | 138.02 | 105.04 | 82.89 | Upgrade
|
Short-Term Debt | 1,488 | 1,525 | 1,066 | 422.96 | 232.93 | 42.35 | Upgrade
|
Current Portion of Long-Term Debt | 8.51 | 48.74 | 46.5 | 79.05 | - | - | Upgrade
|
Current Portion of Leases | - | 8.96 | 9.29 | 14.27 | - | - | Upgrade
|
Current Income Taxes Payable | 20.81 | 17.32 | - | - | 46.44 | 4.5 | Upgrade
|
Current Unearned Revenue | 19.93 | 18.16 | 41.13 | 46.94 | 17.28 | 27 | Upgrade
|
Other Current Liabilities | 36.81 | 23.78 | 8.59 | 3.56 | 24.42 | 18.29 | Upgrade
|
Total Current Liabilities | 2,609 | 2,563 | 2,670 | 1,877 | 1,230 | 737.3 | Upgrade
|
Long-Term Debt | 186.6 | 187.36 | 143.2 | 97.12 | 48.06 | - | Upgrade
|
Long-Term Leases | 32.62 | 28.78 | 21.87 | 23.85 | - | - | Upgrade
|
Long-Term Unearned Revenue | 60.94 | 64.41 | 69.19 | 70.92 | 50.83 | 43.28 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.21 | 1.49 | 9.38 | 13.9 | 6.88 | 0.32 | Upgrade
|
Other Long-Term Liabilities | 5.07 | 5.07 | 7 | 8.15 | 7.34 | 22.2 | Upgrade
|
Total Liabilities | 2,895 | 2,850 | 2,921 | 2,091 | 1,343 | 803.09 | Upgrade
|
Common Stock | 347.98 | 347.98 | 347.98 | 347.98 | 182.22 | 182.22 | Upgrade
|
Additional Paid-In Capital | 1,463 | 1,456 | 1,490 | 1,493 | 724.14 | 704.3 | Upgrade
|
Retained Earnings | 1,810 | 1,742 | 1,715 | 1,869 | 1,761 | 1,177 | Upgrade
|
Treasury Stock | -85.79 | -58 | -58 | - | -14.18 | -26.35 | Upgrade
|
Comprehensive Income & Other | -0.14 | -0.14 | -0.14 | -0.14 | 893.92 | -0.14 | Upgrade
|
Shareholders' Equity | 3,535 | 3,488 | 3,495 | 3,709 | 3,547 | 2,037 | Upgrade
|
Total Liabilities & Equity | 6,430 | 6,338 | 6,416 | 5,801 | 4,890 | 2,840 | Upgrade
|
Total Debt | 1,715 | 1,799 | 1,287 | 637.26 | 280.99 | 42.35 | Upgrade
|
Net Cash (Debt) | -1,220 | -1,373 | -810.23 | -87.56 | 1,053 | 106.72 | Upgrade
|
Net Cash Growth | - | - | - | - | 886.81% | 22.24% | Upgrade
|
Net Cash Per Share | -3.49 | -4.01 | -2.32 | -0.25 | 3.24 | 0.33 | Upgrade
|
Filing Date Shares Outstanding | 343.93 | 343.93 | 347.98 | 347.98 | 328 | 328 | Upgrade
|
Total Common Shares Outstanding | 343.93 | 345.57 | 347.98 | 347.98 | 328 | 328 | Upgrade
|
Working Capital | 390.12 | 388.06 | 347.65 | 954.76 | 1,681 | 743.64 | Upgrade
|
Book Value Per Share | 10.28 | 10.09 | 10.04 | 10.66 | 10.81 | 6.21 | Upgrade
|
Tangible Book Value | 3,139 | 3,113 | 3,128 | 3,334 | 3,305 | 1,871 | Upgrade
|
Tangible Book Value Per Share | 9.13 | 9.01 | 8.99 | 9.58 | 10.08 | 5.71 | Upgrade
|
Buildings | - | 1,056 | 1,000 | 798.58 | 619.24 | 410.2 | Upgrade
|
Machinery | - | 2,646 | 2,316 | 1,831 | 1,243 | 1,004 | Upgrade
|
Construction In Progress | - | 298.59 | 439.07 | 556.36 | 396.13 | 237.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.